Cargando…

Chemoradiotherapy vs radiotherapy for nonoperative early stage esophageal cancer: A seer data analysis

BACKGROUND: The benefit of endoscopic treatment (ET) and esophagectomy for early esophageal cancer (EC) has been sufficiently recognized. Radiotherapy (RT) is the main treatment modality for patients who do not undergo surgery. The effectiveness of adding chemotherapy (CT) to RT remains unclear. Thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jiaxin, Jia, Yibin, Cheng, Yufeng, Wang, Jianbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367638/ https://www.ncbi.nlm.nih.gov/pubmed/32441890 http://dx.doi.org/10.1002/cam4.3132

Ejemplares similares

The effect of surgery plus chemoradiotherapy on survival of elderly patients with stage Ⅱ–Ⅲ esophageal cancer: a SEER‐based demographic analysis
por: Lv, Hao, et al.
Publicado: (2021)

Feasibility and efficiency of concurrent chemoradiotherapy with a single agent or double agents vs radiotherapy alone for elderly patients with esophageal squamous cell carcinoma: Experience of two centers
por: Huang, Chunyue, et al.
Publicado: (2019)

Radiotherapy improves the survival of patients with stage IV NSCLC: A propensity score matched analysis of the SEER database
por: Zhang, Rui, et al.
Publicado: (2018)

Severity of comorbid conditions and early-stage breast cancer therapy: linked SEER-medicare data from 1993 to 2005
por: Yasmeen, Shagufta, et al.
Publicado: (2013)

Preliminary treatment results of proton beam therapy with chemoradiotherapy for stage I–III esophageal cancer
por: Takada, Akinori, et al.
Publicado: (2016)

The stage‐specific roles of radiotherapy and chemotherapy in nodular lymphocyte predominant Hodgkin lymphoma patients: a propensity score‐matched analysis of the SEER database
por: Wang, Shijie, et al.
Publicado: (2020)

Evaluating the eighth edition TNM staging system for esophageal cancer among patients receiving neoadjuvant therapy: A SEER study
por: Yuan, Yonggang, et al.
Publicado: (2020)

The Safety and Efficacy of Apatinib Treatment in Addition to Concurrent Chemoradiotherapy in Patients with Nonoperative Locally Advanced Esophageal Squamous Cell Carcinoma
por: Hu, Lijun, et al.
Publicado: (2020)

National Cancer Database Comparison of Radical Cystectomy vs Chemoradiotherapy for Muscle‐Invasive Bladder Cancer: Implications of Using Clinical vs Pathologic Staging
por: Lin, Hong‐Yiou, et al.
Publicado: (2018)

Clinical outcomes of locally advanced esophageal neuroendocrine carcinoma treated with chemoradiotherapy
por: Honma, Yoshitaka, et al.
Publicado: (2019)

The efficacy and safety of definitive concurrent chemoradiotherapy for non‐operable esophageal cancer
por: Dreyfuss, Alexandra D., et al.
Publicado: (2021)

Clinical response to chemoradiotherapy in esophageal carcinoma is associated with survival and benefit of consolidation chemotherapy
por: Zhao, Zongxing, et al.
Publicado: (2020)

Cytomegalovirus reactivation in esophageal cancer patients receiving chemoradiotherapy: A retrospective analysis
por: Kitagawa, Koichi, et al.
Publicado: (2021)

Practice patterns and outcomes of chemoradiotherapy versus radiotherapy alone for older patients with nasopharyngeal cancer
por: Verma, Vivek, et al.
Publicado: (2018)

Development and prospective validation of a risk score model in guiding individualized concurrent chemoradiotherapy in stage II nasopharyngeal carcinoma in intensity‐modulated radiotherapy era
por: Yang, Shan‐Shan, et al.
Publicado: (2021)

Bone marrow dosimetric analysis of lymphopenia in patients with esophageal squamous cell carcinoma treated with chemoradiotherapy
por: Wang, Qian, et al.
Publicado: (2021)

Failure patterns after adjuvant chemoradiotherapy following endoscopic resection for superficial esophageal squamous cell carcinoma
por: Ikawa, Toshiki, et al.
Publicado: (2019)

YAP1 amplification as a prognostic factor of definitive chemoradiotherapy in nonsurgical esophageal squamous cell carcinoma
por: Dai, Honghai, et al.
Publicado: (2019)

Trends in survival of patients with stage I/II Burkitt lymphoma in the United States: A SEER database analysis
por: Liu, Ze‐Long, et al.
Publicado: (2019)

Comparative effectiveness of radiotherapy for early‐stage hormone receptor‐positive breast cancer in elderly women using real‐world data
por: Ali, Askal A., et al.
Publicado: (2018)

Comparison  of  efficacy, safety, and costs between neoadjuvant hypofractionated radiotherapy and conventionally fractionated radiotherapy for esophageal carcinoma
por: Lyu, Jiahua, et al.
Publicado: (2019)

Real‐world experience of carfilzomib‐associated cardiovascular adverse events: SEER‐Medicare data set analysis
por: Bishnoi, Rohit, et al.
Publicado: (2020)

Limb‐sparing surgery plus radiotherapy results in superior survival: an analysis of patients with high‐grade, extremity soft‐tissue sarcoma from the NCDB and SEER
por: Ramey, Stephen J., et al.
Publicado: (2018)

Worth it or not? Primary tumor resection for stage IV pancreatic cancer patients: A SEER‐based analysis of 15,836 cases
por: Fu, Ningzhen, et al.
Publicado: (2021)

D2‐resected stage IIIc gastric cancer patients benefit from adjuvant chemoradiotherapy
por: Peng, Jin, et al.
Publicado: (2016)

Poor prognostic and staging value of tumor deposit in locally advanced rectal cancer with neoadjuvant chemoradiotherapy
por: Wang, Yaqi, et al.
Publicado: (2019)

Value of radiotherapy in addition to esophagectomy for stage II and III thoracic esophageal squamous cell carcinoma: Analysis of surveillance, epidemiology, and end results database
por: Yu, Jing, et al.
Publicado: (2018)

Prognostic value of tumor length and diameter for esophageal squamous cell cancer patients treated with definitive (chemo)radiotherapy: Potential indicators for nonsurgical T staging
por: Xu, Hongyao, et al.
Publicado: (2019)

Survival following radiotherapy in young women with localized early‐stage breast cancer according to molecular subtypes
por: Liu, Qi‐Qi, et al.
Publicado: (2019)

Improving survival of stage II‐III primary gastric signet ring cell carcinoma by adjuvant chemoradiotherapy
por: Li, Yang, et al.
Publicado: (2020)

Treatment of advanced gallbladder cancer: A SEER‐based study
por: Mao, Weipu, et al.
Publicado: (2019)

Aging‐related prognosis analysis of definitive radiotherapy for very elderly esophageal cancer
por: Zhou, Yong‐Chun, et al.
Publicado: (2018)

Surgery and adjuvant radiotherapy vs concurrent chemoradiotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer: a randomised comparison
por: Soo, K-C, et al.
Publicado: (2005)

Chemoradiotherapy Is Superior to Radiotherapy Alone in Esophageal Cancer Patients Older Than 65 Years: A Propensity Score-Matched Analysis of the SEER Database
por: Xia, Xiaojie, et al.
Publicado: (2021)

Real‐world outcomes of chemoradiotherapy for unresectable Stage III non‐small cell lung cancer: The SOLUTION study
por: Horinouchi, Hidehito, et al.
Publicado: (2020)

Association Between Lymphopenia and Survival Outcomes in Esophageal Carcinoma Patients Receiving Combined Immunotherapy and Chemoradiotherapy
por: Cheng, Xingyuan, et al.
Publicado: (2023)

Primary small cell carcinoma of the esophagus: Comparison between a Chinese cohort and Surveillance, Epidemiology, and End Results (SEER) data
por: Xiao, Qin, et al.
Publicado: (2019)

Utilization of novel systemic therapies for multiple myeloma: A retrospective study of front‐line regimens using the SEER‐Medicare data
por: Goto, Daisuke, et al.
Publicado: (2019)

Minimally invasive surgery vs laparotomy for early stage cervical cancer: A propensity score‐matched cohort study
por: Dai, Danian, et al.
Publicado: (2020)

The effect of surgery on primary splenic lymphoma: A study based on SEER database
por: Pan, Xiaotao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vv4kd24eu6674e1lmb5po1av4u